STEM CELL THERAPY FOR COMMUNITY ACQUIRED PNEUMONIA INDUCED SEPSIS

SEPCELL at the International Society for Cell Therapy 2017 Annual Meeting | May 3-6, London, UK

Dr. Eleuterio Lombardo, Scientific Director at TiGenix, was invited to present the SEPCELL Consortium and trial on the pre-conference workshop “State of the Art on European MSC Clinical Trials” on May 3rd.

This workshop, organized by the International Society for Cell Therapy (ISCT) and the European Commission, addressed the latest updates from European thought leaders in advanced MSC clinical trials from MSC biology and manufacturing, to musculo-skeletal applications, to critical perspectives on clinical use.

More info: http://isct2017.com/state-of-the-art-in-european-msc-clinical-trials/

We use [own and third parties] cookies to analyse the use of our website and improve our services. If you continue visiting the website you are agreeing our cookies policy. You can change the configuration of the cookies and obtain additional information.

MORE INFO